Digital Twins in Healthcare Market by Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2030
The global digital twin healthcare market is experiencing significant growth in 2024, driven by the growing applications of digital twins in healthcare and growing investments by public & private entities. The market is projected to reach USD 59.94 billion by 2030 from USD 4.47 billion in 2025, at a CAGR of 68.0% during the forecast period. Public and private entities increasingly invest in digital twin technologies, recognizing their potential to drive innovation and enhance operational efficiency. Quibim, based in Valencia, is at the forefront of using imaging biomarkers for precision medicine. The company has recently completed a Series A funding round worth USD 50.6 million to establish a presence in the United States. Quibim views this as a significant step towards creating human digital twins—dynamic models that enable health monitoring and improve patient stratification, increase drug development success rates, and facilitate treatment testing before implementation.
“By application, the surgical planning & medical education segment accounted for the largest share of the market in 2024.”
In 2024, the surgical planning & medical education application segment accounted for the largest share of the market. The growth of this segment is due to the integration of digital twins with virtual reality platforms, which enhances surgical training for residents. This technology allows them to simulate procedures tailored to patients' unique anatomical and physiological characteristics. As a result, trainees can experience a realistic representation of performance and track intraoperative metrics. Several companies have developed simulations of medical anatomy and surgical procedures to reduce the reliance on cadavers and promote interactive learning.
“By end user, the healthcare providers segment accounted for the largest share of the market in 2024.”
By end user, the healthcare providers segment accounted for the largest share of the market in 2024. The growth of this segment is attributed to its important role in workflow management and surgical planning. Digital twins offer additional benefits, such as accurate patient modeling, personalized treatment planning, and ongoing monitoring. These advantages contribute to enhanced clinical decision-making and improved patient outcomes.
“By region, Europe accounted for the second-largest market share in 2024.”
Europe accounted for the second-largest share of the market in 2024. Factors influencing advancements in healthcare include increased technological investments and the use of digital twins for research and genomics. According to the European Institute of Innovation & Technology (EIT) Health Germany, European nations are implementing digital twins to improve medication prescriptions. For example, the French company ExactCure, which specializes in digital health, is focused on preventing adverse drug effects. By utilizing cutting-edge omics, sensing, computing, and communication technologies, DigiTwins aims to enable completely personalized and preventive medicine, leading to a paradigm shift in healthcare.
The breakdown of primary participants is as mentioned below:
The key players operating in the digital twin in healthcare market include Microsoft Corporation (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Amazon Web Services, Inc. (US), Dassault Systиmes (France), GE Healthcare (US), IBM (US), NVIDIA Corporation (US), Oracle Corporation (US), PTC (US), SAP (Germany), Atos SE (France), ANSYS, Inc. (US), Faststream Technologies (US), Rescale, Inc. (US), Twin Health (US), NUREA (France), Predictiv (US), Verto (Canada), Qbio (US), Virtonomy GmbH (Germany), Unlearn.ai, Inc. (US), ThoughtWire (Canada), Sim and Cure (France), and PrediSurge (France).
Research Coverage:
The report analyzes the Digital Twins in Healthcare Market. It aims to estimate the market size and future growth potential of various market segments based on type, component, application, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms and new entrants/smaller firms to gauge the market's pulse, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.
This report provides insights on:
“By application, the surgical planning & medical education segment accounted for the largest share of the market in 2024.”
In 2024, the surgical planning & medical education application segment accounted for the largest share of the market. The growth of this segment is due to the integration of digital twins with virtual reality platforms, which enhances surgical training for residents. This technology allows them to simulate procedures tailored to patients' unique anatomical and physiological characteristics. As a result, trainees can experience a realistic representation of performance and track intraoperative metrics. Several companies have developed simulations of medical anatomy and surgical procedures to reduce the reliance on cadavers and promote interactive learning.
“By end user, the healthcare providers segment accounted for the largest share of the market in 2024.”
By end user, the healthcare providers segment accounted for the largest share of the market in 2024. The growth of this segment is attributed to its important role in workflow management and surgical planning. Digital twins offer additional benefits, such as accurate patient modeling, personalized treatment planning, and ongoing monitoring. These advantages contribute to enhanced clinical decision-making and improved patient outcomes.
“By region, Europe accounted for the second-largest market share in 2024.”
Europe accounted for the second-largest share of the market in 2024. Factors influencing advancements in healthcare include increased technological investments and the use of digital twins for research and genomics. According to the European Institute of Innovation & Technology (EIT) Health Germany, European nations are implementing digital twins to improve medication prescriptions. For example, the French company ExactCure, which specializes in digital health, is focused on preventing adverse drug effects. By utilizing cutting-edge omics, sensing, computing, and communication technologies, DigiTwins aims to enable completely personalized and preventive medicine, leading to a paradigm shift in healthcare.
The breakdown of primary participants is as mentioned below:
- By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
- By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
- By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.
The key players operating in the digital twin in healthcare market include Microsoft Corporation (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Amazon Web Services, Inc. (US), Dassault Systиmes (France), GE Healthcare (US), IBM (US), NVIDIA Corporation (US), Oracle Corporation (US), PTC (US), SAP (Germany), Atos SE (France), ANSYS, Inc. (US), Faststream Technologies (US), Rescale, Inc. (US), Twin Health (US), NUREA (France), Predictiv (US), Verto (Canada), Qbio (US), Virtonomy GmbH (Germany), Unlearn.ai, Inc. (US), ThoughtWire (Canada), Sim and Cure (France), and PrediSurge (France).
Research Coverage:
The report analyzes the Digital Twins in Healthcare Market. It aims to estimate the market size and future growth potential of various market segments based on type, component, application, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms and new entrants/smaller firms to gauge the market's pulse, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.
This report provides insights on:
- Analysis of key drivers (increasing Investments in digital twins in developed as well as emerging technology adoption, rising demand for personalized medicine, increasing funding and investments in digital twin startups), restraints (accuracy and privacy issues with digital twin systems and high implementation costs), opportunities (growing importance of digital twin Iin emerging market, increasing focus on cutting edge real-time data analytics), and challenges (lack of technical expertise & data management issues) influencing the growth of the digital twin market
- Product/Service Development & Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the digital twins in healthcare market
- Market Development: Comprehensive information on the lucrative emerging markets by type, component, application, end user, and region
- Market Diversification: Comprehensive information about product portfolios, expanding geographies, recent developments, and investments in the market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the digital twins in healthcare market
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS & REGIONS COVERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.1.2.3 Insights from primary experts
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN DATA TRIANGULATION
2.4 STUDY ASSUMPTIONS
2.5 RISK ASSESSMENT
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 DIGITAL TWINS IN HEALTHCARE MARKET OVERVIEW
4.2 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY COMPONENT AND COUNTRY (2025)
4.3 DIGITAL TWINS IN HEALTHCARE MARKET: COUNTRY MIX
4.4 DIGITAL TWINS IN HEALTHCARE MARKET: REGIONAL MIX
4.5 DIGITAL TWINS IN HEALTHCARE MARKET:
DEVELOPED MARKETS VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Increasing investments by public and private entities
5.2.1.2 Growing applications of digital twins
5.2.1.3 Technological advancements
5.2.1.4 Growing funding and investments in digital twin startups
5.2.2 RESTRAINTS
5.2.2.1 Managing data quality, privacy issues, and
high implementation costs
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing focus on cutting-edge real-time data analytics
5.2.3.2 Growing importance of digital twins in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled professionals
5.2.4.2 Integration with existing systems and outdated digital infrastructure
5.3 INDUSTRY TRENDS
5.3.1 TRANSFORMATION IN CLINICAL TRIALS
5.3.2 REVOLUTIONIZING MEDICAL TRAINING AND DIAGNOSTICS
5.3.3 IMPROVING OPERATIONAL EFFICIENCY IN HOSPITALS
5.4 TECHNOLOGY ANALYSIS
5.4.1 TECHNOLOGY STACK
5.4.1.1 5G networks
5.4.1.2 Internet of Things
5.4.1.3 Cloud and edge computing
5.4.1.4 Blockchain
5.4.1.5 Augmented reality, virtual reality, and mixed reality
5.4.1.6 Artificial intelligence and machine learning
5.5 PORTER’S FIVE FORCES ANALYSIS
5.5.1 INTENSITY OF COMPETITIVE RIVALRY
5.5.2 BARGAINING POWER OF SUPPLIERS
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 THREAT OF NEW ENTRANTS
5.5.5 THREAT OF SUBSTITUTES
5.6 REGULATORY LANDSCAPE
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 VALUE CHAIN ANALYSIS
5.7.1 PLANNING & REVISING FUNDS
5.7.2 RESEARCH & DEVELOPMENT
5.7.3 SOFTWARE DESIGN, FRAMEWORK, AND DEVELOPMENT
5.7.4 PRODUCT/SOLUTION PROVIDERS
5.7.5 END USERS AND AFTER-SALES SERVICE PROVIDERS
5.8 ECOSYSTEM ANALYSIS
5.9 PATENT ANALYSIS
5.9.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.10 ADJACENT MARKET ANALYSIS
5.11 CASE STUDY ANALYSIS
5.11.1 UTILIZATION OF DIGITAL TWIN TECHNOLOGY FOR
SURGE PLANNING DECISIONS
5.11.2 PROVISION OF HOSPITAL GUIDANCE USING DIGITAL TWINS IN
HEALTHCARE DURING COVID-19 PANDEMIC
5.11.3 OPTIMIZATION OF CARDIOVASCULAR SOLUTIONS FOR
PERSONALIZED TREATMENTS
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.12.2 BUYING CRITERIA
5.13 KEY CONFERENCES & EVENTS, 2025?2026
5.14 TRENDS/DISRUPTIONS IMPACTING BUYERS
6 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT
6.1 INTRODUCTION
6.2 SERVICES
6.2.1 INTRODUCTION OF COMPLEX SOFTWARE TO BOOST DEMAND
6.3 SOFTWARE
6.3.1 TRANSITION TO WEB/CLOUD-BASED MODELS TO PROPEL MARKET
7 DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE
7.1 INTRODUCTION
7.2 PROCESS TWINS
7.2.1 RISING DEMAND FOR HEALTHCARE WORKFLOWS AND OPERATIONAL PROCESSES TO DRIVE MARKET
7.3 SYSTEM TWINS
7.3.1 INCREASING DEMAND FOR OPERATIONAL EFFICIENCY IN HOSPITALS TO FUEL MARKET
7.4 WHOLE BODY TWINS
7.4.1 TECHNOLOGICAL ADVANCEMENTS SUCH AS AI AND ML TO FUEL MARKET
7.5 BODY PART TWINS
7.5.1 GRADUAL PREFERENCE FOR PERSONALIZED & PRECISION
MEDICINE TO SUPPORT MARKET GROWTH
8 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 DRUG DISCOVERY & DEVELOPMENT
8.2.1 ABILITY OF DIGITAL TWINS TO ENHANCE DRUG DISCOVERY &
DEVELOPMENT TO BOOST MARKET
8.3 PERSONALIZED MEDICINE
8.3.1 COST-EFFECTIVE DEVELOPMENT & TESTING OF PERSONALIZED DIAGNOSTICS TO SUPPORT MARKET GROWTH
8.4 SURGICAL PLANNING & MEDICAL EDUCATION
8.4.1 ABILITY ENHANCE TRAINING AND SIMULATE SURGICAL PROCEDURES TO BOOST DEMAND
8.5 MEDICAL DEVICE DESIGN & TESTING
8.5.1 MINIMIZING RISKS AND REDUCING DOWNTIME TO DRIVE MARKET
8.6 HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT
8.6.1 ADVANTAGES SUCH AS IMPROVED EFFICIENCY AND
VALUABLE INSIGHTS TO SUPPORT DEMAND
8.7 OTHER APPLICATIONS
9 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER
9.1 INTRODUCTION
9.2 PHARMA & BIOPHARMA COMPANIES
9.2.1 RISING DEMAND FOR SOLUTIONS TO REDUCE TIME AND
COST OF DRUG DEVELOPMENT TO BOOST ADOPTION
9.3 RESEARCH & ACADEMIA
9.3.1 INTERACTIVE AND IMMERSIVE LEARNING EXPERIENCES OFFERED
BY DIGITAL TWINS TO BOOST ADOPTION
9.4 HEALTHCARE PROVIDERS
9.4.1 LOWER COSTS AND BETTER PATIENT TREATMENT TO FAVOR MARKET GROWTH
9.5 MEDICAL DEVICE COMPANIES
9.5.1 GROWING USE OF DIGITAL TWINS FOR SOFTWARE OPTIMIZATION
OF MEDICAL DEVICES TO FUEL GROWTH
9.6 OTHER END USERS
10 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Expanding applications of digital twins in healthcare to
bolster market growth
10.2.3 CANADA
10.2.3.1 Growing investments in digital twin development to drive market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Collaborations & partnerships to drive adoption of digital twins
10.3.3 UK
10.3.3.1 Growing applications of digital twins to support growth
10.3.4 FRANCE
10.3.4.1 Growing government funding for digital twin development to
bolster growth
10.3.5 ITALY
10.3.5.1 Rising focus on digital transformation for value-centric patient care to drive market
10.3.6 SPAIN
10.3.6.1 Rising funding investments for digital health plans to boost market
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Growing penetration of digital twin technologies to
support market growth
10.4.3 CHINA
10.4.3.1 China to register highest CAGR during forecast period
10.4.4 INDIA
10.4.4.1 Improvements in healthcare infrastructure to support market growth
10.4.5 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Favorable digitization investments to support market growth
10.5.3 MEXICO
10.5.3.1 Supportive government strategies to fuel uptake
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Increasing healthcare infrastructure development and investments to support market growth
10.6.3 REST OF MIDDLE EAST AND AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL TWINS IN HEALTHCARE MARKET
11.3 REVENUE ANALYSIS, 2020?2024
11.4 MARKET SHARE ANALYSIS, 2024
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1 Region footprint
11.5.5.2 Company footprint
11.5.5.3 Component footprint
11.5.5.4 Application footprint
11.5.5.5 End-user footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.6.5.1 Detailed list of key startups/SME players
11.6.5.2 Competitive benchmarking of key startups/SME players
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/SOFTWARE COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS
11.9.2 DEALS
11.9.3 EXPANSIONS
11.9.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 MICROSOFT CORPORATION
12.1.1.1 Business overview
12.1.1.2 Products/Services offered
12.1.1.3 Recent developments
12.1.1.3.1 Deals
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 SIEMENS HEALTHINEERS AG
12.1.2.1 Business overview
12.1.2.2 Products/Services offered
12.1.2.3 Recent developments
12.1.2.3.1 Deals
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 KONINKLIJKE PHILIPS N.V.
12.1.3.1 Business overview
12.1.3.2 Products/Services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 AMAZON WEB SERVICES, INC.
12.1.4.1 Business overview
12.1.4.2 Products/Services offered
12.1.4.3 Recent developments
12.1.4.3.1 Product/Service launches & enhancements
12.1.4.3.2 Deals
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 DASSAULT SYSTИMES
12.1.5.1 Business overview
12.1.5.2 Products/Services offered
12.1.5.3 Recent developments
12.1.5.3.1 Product/Service launches & enhancements
12.1.5.3.2 Deals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 GE HEALTHCARE
12.1.6.1 Business overview
12.1.6.2 Products/Services offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 ORACLE CORPORATION
12.1.7.1 Business overview
12.1.7.2 Products/Services offered
12.1.7.3 Recent developments
12.1.7.3.1 Product/Service enhancements
12.1.7.3.2 Deals
12.1.7.3.3 Expansions
12.1.8 IBM
12.1.8.1 Business overview
12.1.8.2 Products/Services offered
12.1.8.3 Recent developments
12.1.8.3.1 Deals
12.1.9 PTC
12.1.9.1 Business overview
12.1.9.2 Products/Services offered
12.1.9.3 Recent developments
12.1.9.3.1 Product/Service launches
12.1.9.3.2 Deals
12.1.10 SAP
12.1.10.1 Business overview
12.1.10.2 Products/Services offered
12.1.10.3 Recent developments
12.1.10.3.1 Deals
12.1.10.3.2 Other developments
12.1.11 ATOS SE
12.1.11.1 Business overview
12.1.11.2 Products/Services offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.12 NVIDIA CORPORATION
12.1.12.1 Business overview
12.1.12.2 Products/Services offered
12.1.12.3 Recent developments
12.1.12.3.1 Product/Service launches
12.1.12.3.2 Deals
12.1.13 ANSYS INC.
12.1.13.1 Business overview
12.1.13.2 Products/Services offered
12.1.13.3 Recent developments
12.1.13.3.1 Product/Service launches
12.1.13.3.2 Deals
12.1.14 FASTSTREAM TECHNOLOGIES
12.1.14.1 Business overview
12.1.14.2 Products/Services offered
12.1.15 RESCALE, INC.
12.1.15.1 Business overview
12.1.15.2 Products/Services offered
12.2 OTHER PAYERS
12.2.1 TWIN HEALTH
12.2.1.1 Business overview
12.2.1.2 Products/Services offered
12.2.1.3 Recent developments
12.2.1.3.1 Other developments
12.2.2 VERTO
12.2.2.1 Business overview
12.2.2.2 Products/Services offered
12.2.2.3 Recent developments
12.2.2.3.1 Deals
12.2.3 QBIO
12.2.3.1 Business overview
12.2.3.2 Products/Services offered
12.2.3.3 Recent developments
12.2.3.3.1 Product/Service launches
12.2.4 THOUGHTWIRE
12.2.4.1 Business overview
12.2.4.2 Products/Services offered
12.2.5 SIM AND CURE
12.2.5.1 Business overview
12.2.5.2 Products/Services offered
12.2.6 PREDICTIV
12.2.6.1 Business overview
12.2.6.2 Products/Services offered
12.2.7 NUREA
12.2.7.1 Business overview
12.2.7.2 Products/Services offered
12.2.7.3 Recent developments
12.2.7.3.1 Product/Service approvals
12.2.7.3.2 Deals
12.2.8 UNLEARN.AI, INC.
12.2.8.1 Business overview
12.2.8.2 Products/Services offered
12.2.8.3 Recent developments
12.2.8.3.1 Deals
12.2.8.3.2 Other developments
12.2.9 VIRTONOMY GMBH
12.2.9.1 Business overview
12.2.9.2 Products/Services offered
12.2.10 PREDISURGE
12.2.10.1 Business overview
12.2.10.2 Products/Services offered
12.2.10.3 Recent developments
12.2.10.3.1 Deals
12.2.10.3.2 Other developments
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS & REGIONS COVERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.1.2.3 Insights from primary experts
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN DATA TRIANGULATION
2.4 STUDY ASSUMPTIONS
2.5 RISK ASSESSMENT
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 DIGITAL TWINS IN HEALTHCARE MARKET OVERVIEW
4.2 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY COMPONENT AND COUNTRY (2025)
4.3 DIGITAL TWINS IN HEALTHCARE MARKET: COUNTRY MIX
4.4 DIGITAL TWINS IN HEALTHCARE MARKET: REGIONAL MIX
4.5 DIGITAL TWINS IN HEALTHCARE MARKET:
DEVELOPED MARKETS VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Increasing investments by public and private entities
5.2.1.2 Growing applications of digital twins
5.2.1.3 Technological advancements
5.2.1.4 Growing funding and investments in digital twin startups
5.2.2 RESTRAINTS
5.2.2.1 Managing data quality, privacy issues, and
high implementation costs
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing focus on cutting-edge real-time data analytics
5.2.3.2 Growing importance of digital twins in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled professionals
5.2.4.2 Integration with existing systems and outdated digital infrastructure
5.3 INDUSTRY TRENDS
5.3.1 TRANSFORMATION IN CLINICAL TRIALS
5.3.2 REVOLUTIONIZING MEDICAL TRAINING AND DIAGNOSTICS
5.3.3 IMPROVING OPERATIONAL EFFICIENCY IN HOSPITALS
5.4 TECHNOLOGY ANALYSIS
5.4.1 TECHNOLOGY STACK
5.4.1.1 5G networks
5.4.1.2 Internet of Things
5.4.1.3 Cloud and edge computing
5.4.1.4 Blockchain
5.4.1.5 Augmented reality, virtual reality, and mixed reality
5.4.1.6 Artificial intelligence and machine learning
5.5 PORTER’S FIVE FORCES ANALYSIS
5.5.1 INTENSITY OF COMPETITIVE RIVALRY
5.5.2 BARGAINING POWER OF SUPPLIERS
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 THREAT OF NEW ENTRANTS
5.5.5 THREAT OF SUBSTITUTES
5.6 REGULATORY LANDSCAPE
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 VALUE CHAIN ANALYSIS
5.7.1 PLANNING & REVISING FUNDS
5.7.2 RESEARCH & DEVELOPMENT
5.7.3 SOFTWARE DESIGN, FRAMEWORK, AND DEVELOPMENT
5.7.4 PRODUCT/SOLUTION PROVIDERS
5.7.5 END USERS AND AFTER-SALES SERVICE PROVIDERS
5.8 ECOSYSTEM ANALYSIS
5.9 PATENT ANALYSIS
5.9.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.10 ADJACENT MARKET ANALYSIS
5.11 CASE STUDY ANALYSIS
5.11.1 UTILIZATION OF DIGITAL TWIN TECHNOLOGY FOR
SURGE PLANNING DECISIONS
5.11.2 PROVISION OF HOSPITAL GUIDANCE USING DIGITAL TWINS IN
HEALTHCARE DURING COVID-19 PANDEMIC
5.11.3 OPTIMIZATION OF CARDIOVASCULAR SOLUTIONS FOR
PERSONALIZED TREATMENTS
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.12.2 BUYING CRITERIA
5.13 KEY CONFERENCES & EVENTS, 2025?2026
5.14 TRENDS/DISRUPTIONS IMPACTING BUYERS
6 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT
6.1 INTRODUCTION
6.2 SERVICES
6.2.1 INTRODUCTION OF COMPLEX SOFTWARE TO BOOST DEMAND
6.3 SOFTWARE
6.3.1 TRANSITION TO WEB/CLOUD-BASED MODELS TO PROPEL MARKET
7 DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE
7.1 INTRODUCTION
7.2 PROCESS TWINS
7.2.1 RISING DEMAND FOR HEALTHCARE WORKFLOWS AND OPERATIONAL PROCESSES TO DRIVE MARKET
7.3 SYSTEM TWINS
7.3.1 INCREASING DEMAND FOR OPERATIONAL EFFICIENCY IN HOSPITALS TO FUEL MARKET
7.4 WHOLE BODY TWINS
7.4.1 TECHNOLOGICAL ADVANCEMENTS SUCH AS AI AND ML TO FUEL MARKET
7.5 BODY PART TWINS
7.5.1 GRADUAL PREFERENCE FOR PERSONALIZED & PRECISION
MEDICINE TO SUPPORT MARKET GROWTH
8 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 DRUG DISCOVERY & DEVELOPMENT
8.2.1 ABILITY OF DIGITAL TWINS TO ENHANCE DRUG DISCOVERY &
DEVELOPMENT TO BOOST MARKET
8.3 PERSONALIZED MEDICINE
8.3.1 COST-EFFECTIVE DEVELOPMENT & TESTING OF PERSONALIZED DIAGNOSTICS TO SUPPORT MARKET GROWTH
8.4 SURGICAL PLANNING & MEDICAL EDUCATION
8.4.1 ABILITY ENHANCE TRAINING AND SIMULATE SURGICAL PROCEDURES TO BOOST DEMAND
8.5 MEDICAL DEVICE DESIGN & TESTING
8.5.1 MINIMIZING RISKS AND REDUCING DOWNTIME TO DRIVE MARKET
8.6 HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT
8.6.1 ADVANTAGES SUCH AS IMPROVED EFFICIENCY AND
VALUABLE INSIGHTS TO SUPPORT DEMAND
8.7 OTHER APPLICATIONS
9 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER
9.1 INTRODUCTION
9.2 PHARMA & BIOPHARMA COMPANIES
9.2.1 RISING DEMAND FOR SOLUTIONS TO REDUCE TIME AND
COST OF DRUG DEVELOPMENT TO BOOST ADOPTION
9.3 RESEARCH & ACADEMIA
9.3.1 INTERACTIVE AND IMMERSIVE LEARNING EXPERIENCES OFFERED
BY DIGITAL TWINS TO BOOST ADOPTION
9.4 HEALTHCARE PROVIDERS
9.4.1 LOWER COSTS AND BETTER PATIENT TREATMENT TO FAVOR MARKET GROWTH
9.5 MEDICAL DEVICE COMPANIES
9.5.1 GROWING USE OF DIGITAL TWINS FOR SOFTWARE OPTIMIZATION
OF MEDICAL DEVICES TO FUEL GROWTH
9.6 OTHER END USERS
10 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Expanding applications of digital twins in healthcare to
bolster market growth
10.2.3 CANADA
10.2.3.1 Growing investments in digital twin development to drive market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Collaborations & partnerships to drive adoption of digital twins
10.3.3 UK
10.3.3.1 Growing applications of digital twins to support growth
10.3.4 FRANCE
10.3.4.1 Growing government funding for digital twin development to
bolster growth
10.3.5 ITALY
10.3.5.1 Rising focus on digital transformation for value-centric patient care to drive market
10.3.6 SPAIN
10.3.6.1 Rising funding investments for digital health plans to boost market
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Growing penetration of digital twin technologies to
support market growth
10.4.3 CHINA
10.4.3.1 China to register highest CAGR during forecast period
10.4.4 INDIA
10.4.4.1 Improvements in healthcare infrastructure to support market growth
10.4.5 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Favorable digitization investments to support market growth
10.5.3 MEXICO
10.5.3.1 Supportive government strategies to fuel uptake
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Increasing healthcare infrastructure development and investments to support market growth
10.6.3 REST OF MIDDLE EAST AND AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL TWINS IN HEALTHCARE MARKET
11.3 REVENUE ANALYSIS, 2020?2024
11.4 MARKET SHARE ANALYSIS, 2024
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1 Region footprint
11.5.5.2 Company footprint
11.5.5.3 Component footprint
11.5.5.4 Application footprint
11.5.5.5 End-user footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.6.5.1 Detailed list of key startups/SME players
11.6.5.2 Competitive benchmarking of key startups/SME players
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/SOFTWARE COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS
11.9.2 DEALS
11.9.3 EXPANSIONS
11.9.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 MICROSOFT CORPORATION
12.1.1.1 Business overview
12.1.1.2 Products/Services offered
12.1.1.3 Recent developments
12.1.1.3.1 Deals
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 SIEMENS HEALTHINEERS AG
12.1.2.1 Business overview
12.1.2.2 Products/Services offered
12.1.2.3 Recent developments
12.1.2.3.1 Deals
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 KONINKLIJKE PHILIPS N.V.
12.1.3.1 Business overview
12.1.3.2 Products/Services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 AMAZON WEB SERVICES, INC.
12.1.4.1 Business overview
12.1.4.2 Products/Services offered
12.1.4.3 Recent developments
12.1.4.3.1 Product/Service launches & enhancements
12.1.4.3.2 Deals
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 DASSAULT SYSTИMES
12.1.5.1 Business overview
12.1.5.2 Products/Services offered
12.1.5.3 Recent developments
12.1.5.3.1 Product/Service launches & enhancements
12.1.5.3.2 Deals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 GE HEALTHCARE
12.1.6.1 Business overview
12.1.6.2 Products/Services offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 ORACLE CORPORATION
12.1.7.1 Business overview
12.1.7.2 Products/Services offered
12.1.7.3 Recent developments
12.1.7.3.1 Product/Service enhancements
12.1.7.3.2 Deals
12.1.7.3.3 Expansions
12.1.8 IBM
12.1.8.1 Business overview
12.1.8.2 Products/Services offered
12.1.8.3 Recent developments
12.1.8.3.1 Deals
12.1.9 PTC
12.1.9.1 Business overview
12.1.9.2 Products/Services offered
12.1.9.3 Recent developments
12.1.9.3.1 Product/Service launches
12.1.9.3.2 Deals
12.1.10 SAP
12.1.10.1 Business overview
12.1.10.2 Products/Services offered
12.1.10.3 Recent developments
12.1.10.3.1 Deals
12.1.10.3.2 Other developments
12.1.11 ATOS SE
12.1.11.1 Business overview
12.1.11.2 Products/Services offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.12 NVIDIA CORPORATION
12.1.12.1 Business overview
12.1.12.2 Products/Services offered
12.1.12.3 Recent developments
12.1.12.3.1 Product/Service launches
12.1.12.3.2 Deals
12.1.13 ANSYS INC.
12.1.13.1 Business overview
12.1.13.2 Products/Services offered
12.1.13.3 Recent developments
12.1.13.3.1 Product/Service launches
12.1.13.3.2 Deals
12.1.14 FASTSTREAM TECHNOLOGIES
12.1.14.1 Business overview
12.1.14.2 Products/Services offered
12.1.15 RESCALE, INC.
12.1.15.1 Business overview
12.1.15.2 Products/Services offered
12.2 OTHER PAYERS
12.2.1 TWIN HEALTH
12.2.1.1 Business overview
12.2.1.2 Products/Services offered
12.2.1.3 Recent developments
12.2.1.3.1 Other developments
12.2.2 VERTO
12.2.2.1 Business overview
12.2.2.2 Products/Services offered
12.2.2.3 Recent developments
12.2.2.3.1 Deals
12.2.3 QBIO
12.2.3.1 Business overview
12.2.3.2 Products/Services offered
12.2.3.3 Recent developments
12.2.3.3.1 Product/Service launches
12.2.4 THOUGHTWIRE
12.2.4.1 Business overview
12.2.4.2 Products/Services offered
12.2.5 SIM AND CURE
12.2.5.1 Business overview
12.2.5.2 Products/Services offered
12.2.6 PREDICTIV
12.2.6.1 Business overview
12.2.6.2 Products/Services offered
12.2.7 NUREA
12.2.7.1 Business overview
12.2.7.2 Products/Services offered
12.2.7.3 Recent developments
12.2.7.3.1 Product/Service approvals
12.2.7.3.2 Deals
12.2.8 UNLEARN.AI, INC.
12.2.8.1 Business overview
12.2.8.2 Products/Services offered
12.2.8.3 Recent developments
12.2.8.3.1 Deals
12.2.8.3.2 Other developments
12.2.9 VIRTONOMY GMBH
12.2.9.1 Business overview
12.2.9.2 Products/Services offered
12.2.10 PREDISURGE
12.2.10.1 Business overview
12.2.10.2 Products/Services offered
12.2.10.3 Recent developments
12.2.10.3.1 Deals
12.2.10.3.2 Other developments
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
